Arkema SA
PAR:AKE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arkema SA
PAR:AKE
|
FR |
|
First Community Bankshares Inc
NASDAQ:FCBC
|
US |
|
Editas Medicine Inc
NASDAQ:EDIT
|
US |
|
Europcar Mobility Group SA
F:E7CD
|
FR |
|
M
|
Moneta Money Bank as
PSE:MONET
|
CZ |
|
S
|
Studentbostader I Norden AB (publ)
STO:STUDBO
|
SE |
|
M
|
Mega Or Holdings Ltd
TASE:MGOR
|
IL |
|
Dare Bioscience Inc
NASDAQ:DARE
|
US |
|
Income Asset Management Group Ltd
ASX:IAM
|
AU |
|
B
|
Baijiayun Group Ltd
NASDAQ:RTC
|
CN |
|
Grail Inc
NASDAQ:GRAL
|
US |
Wall Street
Price Targets
AKE Price Targets Summary
Arkema SA
According to Wall Street analysts, the average 1-year price target for
AKE
is 64.4 EUR
with a low forecast of 44.44 EUR and a high forecast of 84 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AKE's stock price target?
Price Target
64.4
EUR
According to Wall Street analysts, the average 1-year price target for
AKE
is 64.4 EUR
with a low forecast of 44.44 EUR and a high forecast of 84 EUR.
What is Arkema SA's Revenue forecast?
Projected CAGR
2%
For the last 14 years the
compound annual growth rate for
Arkema SA's revenue is
3%.
The projected
CAGR
for the next 3 years is
2%.
What is Arkema SA's Operating Income forecast?
Projected CAGR
19%
For the last 14 years the
compound annual growth rate for
Arkema SA's operating income is
-4%.
The projected
CAGR
for the next 3 years is
19%.
What is Arkema SA's Net Income forecast?
Projected CAGR
134%
The
compound annual growth rate
of Arkema SA's net income for the next 3 years is
134%.
